3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
39
Pancreatic Neoplasms
19
Stomach Neoplasms
13
Colonic Neoplasms
12
Carcinoma, Non-Small-Cell Lung
11
Adenocarcinoma Of Esophagus
11
Rectal Neoplasms
10
Neoplasm Metastasis
10
Burkitt Lymphoma
10
Neoplasms
9
Esophageal Neoplasms
9
Cholangiocarcinoma
6
Adenocarcinoma
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Lung Neoplasms
4
Leukemia, Biphenotypic, Acute
4
Esophageal Squamous Cell Carcinoma
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Ovarian Neoplasms
3
Gallbladder Neoplasms
3
Endometrial Neoplasms
3
Advanced Solid Tumors
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Lymphoma
2
Gastrointestinal Neoplasms
2
Down Syndrome
2
Carcinoma, Renal Cell
2
Interventions
fludarabine
4
Cyclophosphamide
4
fludarabine phosphate
3
Melphalan
3
pembrolizumab
2
obinutuzumab
2
blinatumomab
2
Rituximab
2
Radiotherapy
2
Lenalidomide
2
Capecitabine
2
Blood Specimen Collection
2
trastuzumab deruxtecan
1
tislelizumab
1
tisagenlecleucel
1
thymoglobulin
1
tetrathiomolybdate
1
talquetamab
1
sacituzumab govitecan
1
palbociclib
1
nilotinib
1
isatuximab
1
avelumab
1
atezolizumab
1
acalabrutinib
1
Whole-Body Irradiation
1
Trastuzumab
1
Sirolimus
1
Neoadjuvant Therapy
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm, Residual
×
Leucovorin
×
90 days
×
Clear all
No trials found.